REBETOL

Показания к применению

Хронический гепатит С (у первичных больных, ранее не лечившихся интерфероном альфа; при обострении после курса монотерапии интерфероном альфа; у больных, невосприимчивых к монотерапии интерфероном альфа) - в комбинации с интерфероном альфа. Геморрагическая лихорадка с почечным синдромом (для в/в введения).

Действующее вещество:

RIBAVIRIN

Описание препарата на английском

Tritherapy:Rebetol in combination with boceprevir and peginterferon alfa-2b is indicated for the treatment of chronic hepatitis C (CHC) genotype1 infection in adults patients (18 years of age and older) with compensated liver disease who are previously untreated or who have failed previous therapy.Bitherapy:Rebetol is indicated for the treatment of chronic hepatitis C virus infection in adults and must only be used as part of a combination regimen with peginterferon alfa-2b or interferon alfa-2b .Rebetol monotherapy must not be used. There is no safety or efficacy information on the use of Rebetol with other forms of interferon (i.e., not alfa-2b).Previously untreated (na?ve) patientsAdult patients (18 years of age or older): Rebetol is indicated for:• tritherapy- in combination with peginterferon alfa-2b and boceprevir for the treatment of adult patients with chronic hepatitis C genotype1 infection with compensated liver disease.• bitherapy- in combination with interferon alfa-2b or peginterferon alfa-2b, for the treatment of adult patients with chronic hepatitis C, not previously treated, without liver decompensation, with elevated alanine aminotransferase (ALT), who are positive for hepatitis C viral ribonucleic acid (HCV-RNA).• bitherapy- for the treatment of CHC infection in combination with peginterferon alfa-2b for patients with compensated cirrhosis and/or clinically stable HIV co-infection. • Previously treated patientsAdult patients: Rebetol is indicated for:• tritherapy- in combination with peginterferon alfa-2b and boceprevir for the treatment of adult patients having CHC genotype 1 infection with compensated liver disease.• bitherapy- in combination with peginterferon alfa-2b, for the treatment of patients with chronic hepatitis C who have failed previous treatment with interferon alfa (pegylated or non-pegylated) alone or in combination with ribavirin.• bitherapy-in combination with interferon alfa-2b, for the treatment of patients with chronic hepatitis C who have previously responded (with normalisation of ALT at the end of treatment) to interferon alfa monotherapy but who have subsequently relapsed.

Характеристики
По рецепту по рецепту
Срок годности 24 мес.
Форма употребления CAPSULES

Ссылка на сайт МинЗдрава Израиля: http://www.old.health.gov.il/units/pharmacy/trufot/PerutTrufa.asp?Reg_Number=116 93 29850 01&safa=e


Оставить отзыв

Примечание: HTML разметка не поддерживается! Используйте обычный текст.
    Плохо           Хорошо

Арвирон, Веро-Рибавирин, Виразол, Девирс, Ребетол, Рибавин, Рибавирин, Рибавирин ЛИПИНТ, Рибавирин Медуна, Рибавирин-Био, Рибавирин-ЛЭНС, Рибавирин-ФПО, Рибамидил, Рибапег, Триворин

REBETOL Ребетол - инструкция по применению

    Рекомендуемая цена в аптеках Израиля

Фасовка Цена

* Аптечные цены установлены Министерством здравоохранения Государства Израиль

RIBAVIRIN